<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0361055</journal-id>
<journal-id journal-id-type="pubmed-jr-id">7770</journal-id>
<journal-id journal-id-type="nlm-ta">Toxicology</journal-id>
<journal-id journal-id-type="iso-abbrev">Toxicology</journal-id>
<journal-title-group>
<journal-title>Toxicology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0300-483X</issn>
<issn pub-type="epub">1879-3185</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26551072</article-id>
<article-id pub-id-type="pmc">4724313</article-id>
<article-id pub-id-type="doi">10.1016/j.tox.2015.11.001</article-id>
<article-id pub-id-type="manuscript">NIHMS748841</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mechanisms of Divalent Metal Toxicity in Affective Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Menon</surname>
<given-names>Archita Venugopal</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chang</surname>
<given-names>JuOae</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Jonghan</given-names>
</name>
<email>j.kim@neu.edu</email>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="A1">Department of Pharmaceutical Sciences, Northeastern University, Boston, MA 02115, USA</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>Correspondence author at: Northeastern University, Department of Pharmaceutical Sciences, 360 Huntington Avenue 148TF, Boston, MA 02115; Tel.: 617-373-3214, Fax 617-373-8886</corresp>
<fn fn-type="conflict" id="FN2">
<p id="P45">The authors have no conflicting financial interests.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>6</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>10</day>
<month>11</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<day>2</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>02</day>
<month>1</month>
<year>2017</year>
</pub-date>
<volume>339</volume>
<fpage>58</fpage>
<lpage>72</lpage>
<!--elocation-id from pubmed: 10.1016/j.tox.2015.11.001-->
<abstract>
<p id="P1">Metals are required for proper brain development and play an important role in a number of neurobiological functions. The Divalent Metal Transporter 1 (DMT1) is a major metal transporter involved in the absorption and metabolism of several essential metals like iron and manganese. However, non-essential divalent metals are also transported through this transporter. Therefore, altered expression of DMT1 can modify the absorption of toxic metals and metal-induced toxicity. An accumulating body of evidence has suggested that increased metal stores in the brain are associated with elevated oxidative stress mediated by the ability of metals to catalyze redox reactions, resulting in abnormal neurobehavioral function and the progression of neurodegenerative diseases. Metal overload has also been implicated in impaired emotional behavior, although the underlying mechanisms are not well understood with limited information. The current review focuses on psychiatric dysfunction associated with imbalanced metabolism of metals that are transported by DMT1. The investigations with respect to the toxic effects of metal overload on behavior and their underlying mechanisms of toxicity could provide several new therapeutic targets to treat metal-associated affective disorders.</p>
</abstract>
<kwd-group>
<kwd>Cadmium</kwd>
<kwd>Divalent Metal Transporter 1</kwd>
<kwd>Emotion</kwd>
<kwd>Iron</kwd>
<kwd>Lead</kwd>
<kwd>Manganese</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>